SLC25A1 and neoplasm: In the endoplasmic reticulum of all exponentially growing tumor and normal cells, including leukemic and endothelial cells, APLs inhibit phosphocholine cytidyltransferase (CTP), which catalyzes the rate-limiting step of the de novo PC synthesis (10), which is essential for cell proliferation and is up-regulated in tumor cells.